We also contrasted gene expression in tumours derived from chronic IFNγ stimulated YUMM2.1 cells treated with α-PD-1 monotherapy with α-PD-1 + PARP14i combination therapy treated by sequencing mRNA from bulk tumours. The gene discussed is PDCD1; the disease is neoplasm.